SCHEMBL1930873

SCHEMBL1930873

O=C1CC(Oc2ccccc2)C(=O)O1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DDB1 Q16531 1/20 0.44
CRBN Q96SW2 1/20 0.44
SLC6A2 P23975 4/20 0.40
SLC6A3 Q01959 3/20 0.40
SLC6A4 P31645 3/20 0.37
CTRC Q99895 1/20 0.37
CTRB1 P17538 1/20 0.36
CTSV O60911 1/20 0.36
CTSL P07711 1/20 0.36
CTSB P07858 1/20 0.36
CTSH P09668 1/20 0.36
CTSS P25774 1/20 0.36
CTSK P43235 1/20 0.36
CTSC P53634 1/20 0.36
CTSF Q9UBX1 1/20 0.36
HRH1 P35367 1/20 0.35
NPC1 O15118 1/20 0.35
POLB P06746 1/20 0.35
RAB9A P51151 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13131104 0.87 CTRB1 (0.37) DDB1CRBNSLC6A2SLC6A3CTRC
SCHEMBL13131053 0.86 DDB1 (0.34) DDB1CRBNSLC6A2SLC6A3CTRC
SCHEMBL13130988 0.86 DDB1 (0.34) DDB1CRBNSLC6A2SLC6A3CTRC
SCHEMBL4567673 0.82 HPGD (0.37) ALDH1A1ALDH2HPGD
SCHEMBL13131098 0.81 ALDH1A1 (0.30) ALDH1A1
SCHEMBL13130998 0.76
SCHEMBL13130992 0.75 HPGD (0.33) ALDH1A1ALDH2HPGD
SCHEMBL1930872 0.74 PSEN1 (0.41) CTSVCTSLCTSBCTSSCTSK
SCHEMBL28660105 0.74 PSEN1 (0.41) CTSVCTSLCTSBCTSSCTSK
SCHEMBL13131164 0.73 ACHE (0.31) DDB1CRBNALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8506945-B2 Polymers with structure-defined functions SMITH & NEPHEW, PLC. (GB) 2013-08-13 US disclosed
US-20110300096-A1 Polymers With Structure-Defined Functions GREENER BRYAN (GB) 2011-12-08 US disclosed
US-7955594-B2 Maleic anhydride-methyl vinyl ether copolymers; polyamic acids; medical implant device, dressing, scaffold, or fluid adhesive for treatment or prophylaxis of wounds; enhanced activity of protease inhibitors and neurotransmitter drugs SMITH & NEPHEW, PLC (GB) 2011-06-07 US disclosed
US-20050032929-A1 Polymers with structure-defined functions SMITH & NEPHEW, PLC (GB) 2005-02-10 US disclosed
EP-1436334-A1 POLYMERS WITH STRUCTURE-DEFINED FUNCTIONS Smith & Nephew PLC (GB) 2004-07-14 EP disclosed
WO-2003027154-A1 POLYMERS WITH STRUCTURE-DEFINED FUNCTIONS SMITH & NEPHEW PLC (GB) 2003-04-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110300096-A1 Polymers With Structure-Defined Functions MMP1, MMP8, ADAM12 DDB1 2927/4885CRBN 2978/4885SLC6A2 523/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.